Potential clinical utility of liquid biopsies in ovarian cancer
Abstract Background Ovarian cancer (OC) is the most lethal gynecologic malignancy worldwide. One of the main challenges in the management of OC is the late clinical presentation of disease that results in poor survival. Conventional tissue biopsy methods and serological biomarkers such as CA-125 hav...
Main Authors: | Jie Wei Zhu, Parsa Charkhchi, Mohammad R. Akbari |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-05-01
|
Series: | Molecular Cancer |
Online Access: | https://doi.org/10.1186/s12943-022-01588-8 |
Similar Items
-
What Is Known about Breast Cancer in Young Women?
by: Jie Wei Zhu, et al.
Published: (2023-03-01) -
CA125 and Ovarian Cancer: A Comprehensive Review
by: Parsa Charkhchi, et al.
Published: (2020-12-01) -
Evolving Clinical Utility of Liquid Biopsy in Gastrointestinal Cancers
by: Richard A. Jacobson, et al.
Published: (2019-08-01) -
Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer
by: Haifeng Shen, et al.
Published: (2022-12-01) -
Prostate Cancer Liquid Biopsy Biomarkers’ Clinical Utility in Diagnosis and Prognosis
by: Milena Matuszczak, et al.
Published: (2021-07-01)